Kuster Questions Biden Administration Health Officials, Urges More Research on Long COVID-19 Cases
Concord, March 17, 2021
Concord, N.H. — Today, Rep. Annie Kuster (NH-02), a member of the House Energy and Commerce Oversight and Investigations Subcommittee, participated in a Subcommittee hearing entitled, "Leading the Way Forward: Biden Administration Actions to Increase COVID-19 Vaccinations.” The Oversight and Investigations Subcommittee heard from CDC Director Rochelle P. Walensky M.D., M.P.H., NIH Director Anthony S. Fauci, M.D., and Center for Biologics Evaluation and Research Director Peter Marks, M.D., Ph.D. about the Biden administration’s efforts to expand the production and distribution of COVID-19 vaccines.
“In the weeks since the Biden administration took office, we have been able to seriously turn the tide on this pandemic,” said Rep. Kuster. “Our national effort to get shots into arms has increased, we passed a transformative relief package that will be a game-changer for hardworking families in New Hampshire, and we now have three safe, effective COVID-19 vaccines. While we celebrate these successes, we must also continue to research this virus to stay one step ahead.”
“For months, there have been reports of Americans who have had COVID-19 and continue to suffer from symptoms, a condition commonly referred to as ‘Long Covid,’” Rep. Kuster continued. “My previously healthy 34-year-old niece who first got sick last April continues to have trouble with daily activities as a result of COVID, and she is not alone. I was pleased to see NIH’s announcement last month that it has launched a nationwide initiative to identify the causes and ways to prevent and treat ‘Long COVID.’ This new initiative could help provide more clarity to those suffering, and it is an important reminder that the consequences of this pandemic will remain long after the virus is contained. I will continue working in Congress to ensure our doctors and scientists have the support they need to investigate this virus to keep our communities safe.”
Kuster has been a leading voice in Congress to bolster and quicken our nationwide vaccine rollout. In January, Kuster introduced the Immunization Infrastructure Modernization Act to improve and expand real-time communication between state and federal governments, as well as public and private health care providers, to ensure vaccines are being administered effectively and efficiently across all states and territories. Also this year, Kuster introduced the Coronavirus Vaccine and Therapeutic Development Act to ensure that the United States will be able to mass-produce and administer COVID-19 vaccines and therapeutics quickly and efficiently. Funding modeled after both of these bills was included in the American Rescue Plan Act President Biden signed into law last week.